PharmaFutures was set up in response to the serious challenges facing the pharmaceutical industry and, in particular, the dilemma of meeting short-term profitability for investors while meeting growing societal expectations of effective, affordable and accessible medicines. The aim of this project is to help investors and companies reconcile these competitive tensions to enable the industry to more systematically and strategically address these unmet societal needs.


Innovation remains core to our success, ensuring we research and develop new medicines and vaccines which address unmet medical needs. The Shared Value report outlines how all stakeholders including industry, investors, governments and regulators can play their part in ensuring the appropriate balance between value for money and delivering fair rewards for innovation can be achieved.

Simon Jose, GSK